Live Breaking News & Updates on Acute Pyelonephritis
Stay updated with breaking news from Acute pyelonephritis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The good news is that the U.S. FDA’s complete response letter (CRL) for Venatorx Pharmaceuticals Inc.’s intravenous antibiotic combination, cefepime-taniborbactam, in complicated urinary tract infections (cUTIs) requested no additional clinical testing. The bad news is the inevitable delay for a drug Venatorx and partner Melinta Therapeutics Inc. are aiming to position as a much-needed option for the fight against drug-resistant gram-negative infections. ....
"DelveInsight Business Research LLP"DelveInsight's "Acute Pyelonephritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Acute Pyelonephritis, historical and ....